Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial-Reference-Cited by-同舟云学术

Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial

Published:2023-12 Issue: Volume: Page:
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Kiani-Alikhan Sorena,Gower Richard,Craig Timothy,Wedner H. James,Kinaciyan Tamar,Aygören-Pürsün Emel,Banerji Aleena,Bernstein Jonathan A.,Anderson John,Collis Phil,Johnston Douglas T.,Desai Bhavisha,Tomita Dianne,Gagnon Rémi,Tachdjian Raffi,Soteres Daniel F.,Farkas Henriette,Caballero Teresa,McNeil Donald,Jacobs Joshua,Lumry William R.

Funder

Biocryst Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference35 articles.

1. Hereditary angioedema: examining the landscape of therapies and preclinical therapeutic targets;Farkas;Expert Opin Ther Targets,2019

2. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema;Busse;J Allergy Clin Immunol Pract,2021

3. SERPING1 mutations in 59 families with hereditary angioedema;López-Lera;Mol Immunol,2011

4. Definition and classification of hereditary angioedema;Proper;Allergy Asthma Proc,2020

5. Hereditary angioedema;Busse;N Engl J Med,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary angioedema: current therapeutic management and future approaches;Current Opinion in Allergy & Clinical Immunology;2024-05-13

2. University students' satisfaction with library services and resources using the Kano model;International Journal of ADVANCED AND APPLIED SCIENCES;2024-05

3. Berotralstat for long-term prophylaxis of hereditary angioedema in Japan: Parts 2 and 3 of the randomized APeX-J Phase III trial;World Allergy Organization Journal;2024-03